23390843

Baldani DP

2012

Clinical and biochemical characteristics of polycystic ovary syndrome in Croatian population.

23390858

Kedikova S

2012

[Metformin efficiency for the adolescent PCOS treatment].

23390860

Parahuleva N

2012

[Anti-Mullerian hormone- its role in the pathogenesis of the polycystic ovary syndrome].

23396998

Speca S

2007

The pathogenetic enigma of polycystic ovary syndrome.

23397625

Siu MK

2012

The blood-follicle barrier (BFB) in disease and in ovarian function.

23401041

Wagshul ME

2013

Novel retrospective, respiratory-gating method enables 3D, high resolution, dynamic imaging of the upper airway during tidal breathing.

23407282

Ercan CM

2013

Sexual dysfunction assessment and hormonal correlations in patients with polycystic ovary syndrome.

23408576

Brodin T

2013

Antim?llerian hormone levels are strongly associated with live-birth rates after assisted reproduction.

23409523

Godinjak A

2012

Insulin resistance and lipid accumulation product in corelation to body mass index in women with polycystic ovary syndrome.

23412023

Musacchio MC

2013

[Evaluation of the myo-inositol-monacolin K association on hyperandrogenism and on the lipidic metabolism parameters in PCOS women].

23415973

de Mendon?a-Louzeiro MR

2013

Faster thrombin generation in women with polycystic ovary syndrome compared with healthy controls matched for age and body mass index.

23416841

Stener-Victorin E

2013

Hypothetical physiological and molecular basis for the effect of acupuncture in the treatment of polycystic ovary syndrome.

23417420

Sellix MT

2013

Excess androgen during puberty disrupts circadian organization in female rats.

23419796

Ning N

2013

How to recognize PCOS: results of a web-based survey at IVF-worldwide.com.

23419798

Liu S

2013

Effect of Hsp27 on early embryonic development in the mouse.

23420000

Moran LJ

2013

Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines.

23422073

Insenser M

2013

Proteomic and metabolomic approaches to the study of polycystic ovary syndrome.

23426706

Xiang S

2013

Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome.

23426830

Pawelczak M

2012

Elevated serum anti-M?llerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features.

23426873

Yan X

2013

Prenatal androgen excess programs metabolic derangements in pubertal female rats.

23427231

Gleicher N

2013

Hypoandrogenism in association with diminished functional ovarian reserve.

23427238

Guzman L

2013

A prediction model to select PCOS patients suitable for IVM treatment based on anti-Mullerian hormone and antral follicle count.

23430028

Sun X

2013

Effect of metformin on ovulation and reproductive outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.

23433514

Butler MS

2013

Small glutamine-rich tetratricopeptide repeat-containing protein alpha is present in human ovaries but may not be differentially expressed in relation to polycystic ovary syndrome.

23433744

Abali R

2013

The serum protein ?2-Heremans-Schmid glycoprotein/fetuin-a concentration and carotid intima-media thickness in women with polycystic ovary syndrome.

23434327

El-Mesallamy HO

2013

Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome.

23435443

Ravn P

2013

Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss.

23436925

Gambineri A

2013

Prevalence of hyperandrogenic states in late adolescent and young women: epidemiological survey on italian high-school students.

23438443

Shreeve N

2013

Poor sleep in PCOS; is melatonin the culprit?

23438716

Annag?r BB

2013

Biological correlates of major depression and generalized anxiety disorder in women with polycystic ovary syndrome.

23441473

Pehlivanov BK

2012

Bilateral simultaneous isthmic ectopic pregnancy after clomiphene induction.

23444109

Krupp K

2013

[A questionnaire for the assessment of women's perception of their own femininity: a study on women with Mayer-Rokitansky-Kuster-Hauser-syndrome and women with polycystic ovary syndrome].

23444983

Gower BA

2013

Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS.

23445141

Mohiyiddeen L

2013

Effects of low-dose metformin and rosiglitazone on biochemical, clinical, metabolic and biophysical outcomes in polycystic ovary syndrome.

23448151

Schooling CM

2013

The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials.

23448483

Christakou C

2013

Structural, biochemical and non-traditional cardiovascular risk markers in PCOS.

23448487

Ojeda-Ojeda M

2013

Mediators of low-grade chronic inflammation in polycystic ovary syndrome (PCOS).

23449010

Carmina E

2013

Oral contraceptives and cardiovascular risk in women with polycystic ovary syndrome.

23449943

Diane A

2013

Prior caloric restriction increases survival of prepubertal obese- and PCOS-prone rats exposed to a challenge of time-limited feeding and physical activity.

23450052

Ezeh U

2013

Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females.

23452749

Milsom SR

2013

Polycystic ovary syndrome and depression in New Zealand adolescents.

23454764

Mather KJ

2013

Insulin resistance in the vasculature.

23457541

Rae M

2013

The pancreas is altered by in utero androgen exposure: implications for clinical conditions such as polycystic ovary syndrome (PCOS).

23457588

Salom?ki H

2013

Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood.

23461296

Sahmay S

2013

Anti-M?llerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients.

23461365

Lazaros L

2013

CYP19 gene variants affect the assisted reproduction outcome of women with polycystic ovary syndrome.

23461678

Wu J

2014

Elevated serum thioredoxin-interacting protein in women with polycystic ovary syndrome is associated with insulin resistance.

23461768

Arefi S

2013

Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs).

23461841

Muneyyirci-Delale O

2013

Serum free fatty acid levels in PCOS patients treated with glucophage, magnesium oxide and spironolactone.

23462509

Okoroh EM

2013

Reply: To PMID 22959762.

23462511

Kasapoglu T

2013

Do oral contraceptive pills really protect against venous thromboembolism, especially in polycystic ovary syndrome patients? Prescription bias or not?

23462765

Hampton T

2013

NIH panel: Name change, new priorities advised for polycystic ovary syndrome.

23464983

Lunger F

2013

Accurate screening for insulin resistance in PCOS women using fasting insulin concentrations.

23465705

Lindenberg S

2013

New approach in patients with polycystic ovaries, lessons for everyone.

23467955

Minozzi M

2013

The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.

23472949

Dumesic DA

2013

Ontogeny of the ovary in polycystic ovary syndrome.

23476073

Moghetti P

2013

Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.

23477907

Kim JJ

2013

Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.

23478722

Rodrigues de Oliveira Penaforte F

2012

The use of body circumferences for the prediction of intra-abdominal fat in obese women with polycystic ovary syndrome.

23479161

Lecke SB

2013

Association between adipose tissue expression and serum levels of leptin and adiponectin in women with polycystic ovary syndrome.

23480621

Haoula Z

2012

Doppler imaging in the diagnosis of ovarian disease.

23480783

Karakas SE

2013

Free fatty acid binding protein-4 and retinol binding protein-4 in polycystic ovary syndrome: response to simvastatin and metformin therapies.

23480818

Celik C

2013

The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome.

23482444

Johansson J

2013

Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial.

23483766

Bagheri M

2012

Lack of Association of Vitamin D Receptor FokI (rs10735810) (C/T) and BsmI (rs1544410) (A/G) Genetic Variations with Polycystic Ovary Syndrome Risk: a Case-control Study from Iranian Azeri Turkish Women.

23488293

Ciftci CF

2012

Phenotypic subgroups of polycystic ovary syndrome have different intra-renal resistance symptoms.

23488804

Narasimhan A

2013

Estradiol favors glucose oxidation in gastrocnemius muscle through modulation of insulin signaling molecules in adult female rats.

23489701

Hong Y

2013

Insulin resistance in first-trimester pregnant women with pre-pregnant glucose tolerance and history of recurrent spontaneous abortion.

23490536

Coskun A

2013

Plasma selenium levels in Turkish women with polycystic ovary syndrome.

23493574

Chen YH

2013

miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance.

23494540

Cobin RH

2013

Cardiovascular and metabolic risks associated with PCOS.

23496864

Copperman AB

2013

Optimal usage of the GnRH antagonists: a review of the literature.

23498654

Rogenhofer N

2013

Independent association of the M2/ANXA5 haplotype with recurrent pregnancy loss (RPL) in PCOS patients.

23499866

Layman LC

2013

The genetic basis of female reproductive disorders: etiology and clinical testing.

23503943

Lujan ME

2013

Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.

23503972

Sch?ler S

2013

Ovarian epithelial tumors and reproductive factors: a systematic review.

23504292

Chou YC

2013

Characteristics of neurogenic voiding dysfunction in cerebellar stroke: a cross-sectional, retrospective video urodynamic study.

23506275

Casadei L

2013

The role of serum anti-M?llerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome.

23509696

Radenkovi? M

2013

Therapeutic approach in the improvement of endothelial dysfunction: the current state of the art.

23515450

Fuqua JS

2013

Treatment and outcomes of precocious puberty: an update.

23517862

Vitek WS

2013

Estrogen-suppressed in?vitro maturation: a novel approach to?in?vitro maturation.

23518031

Farhi A

2013

Maternal and neonatal health outcomes following assisted reproduction.

23525243

Veiga-Lopez A

2013

Developmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheep.

23527552

Galazis N

2013

Proteomic biomarkers of endometrial cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration.

23528141

Hern?ndez-Mijares A

2013

Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome.

23529348

Mortada R

2013

Utility of hemoglobin-A1C in nondiabetic women with polycystic ovary syndrome.

23529993

Rafraf M

2012

Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome.

23536150

Fu L

2013

Association study between FSHR Ala307Thr and Ser680Asn variants and polycystic ovary syndrome (PCOS) in Northern Chinese Han women.

23538473

Rom?o GS

2013

[Clinical use for anti-mullerian hormone in gynecology].

23539721

Ezeh U

2013

Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome.

23539878

Blair SA

2013

Oxidative stress and inflammation in lean and obese subjects with polycystic ovary syndrome.

23543241

Abu Hashim H

2013

Three decades after Gj?nnaess's laparoscopic ovarian drilling for treatment of PCOS; what do we know? An evidence-based approach.

23543316

G S

2013

Acanthosis Nigricansin PCOS Patients and Its Relation with Type 2 Diabetes Mellitus and Body Mass at a Tertiary Care Hospital in Southern India.

23546603

Connolly F

2013

Excess androgens in utero alters fetal testis development.

23548659

Garelli S

2013

High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome.

23548757

G?zdemir E

2013

Is hepcidin a new cardiovascular risk marker in polycystic ovary syndrome?

23549804

Lee H

2013

Is insulin resistance an intrinsic defect in asian polycystic ovary syndrome?

23550861

Oner G

2013

Efficacy of omega-3 in the treatment of polycystic ovary syndrome.

23550965

Dasgupta S

2013

The role of epistasis in the etiology of Polycystic Ovary Syndrome among Indian women: SNP-SNP and SNP-environment interactions.

23553200

Caglar GS

2013

Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS.